<DOC>
	<DOCNO>NCT02210949</DOCNO>
	<brief_summary>Pre-treatment patient erythropoietin subcutaneously iron supplement intravenously , order create clinical pathway minimize transfusion red blood cell select group cardiac patient increase risk blood transfusion cardiac surgery program .</brief_summary>
	<brief_title>Pre-operative Treatment With Erythropoietin Iron Supplement Cardiac Surgery</brief_title>
	<detailed_description>Blood transfusion identify independent predictor early mortality Coronary artery bypass graft operation In addition , female gender , low body surface area ( BSA ) , low preoperative Hemoglobin ( Hb ) , previous cardiac surgery , emergency operation low preoperative creatinin clearance find independent risk factor receive Red Blood Cells ( RBC ) unit . We create clinical pathway reduce transfusion red blood cell pretreating patient erythropoietin iron determine reduction number patient receive blood transfusion perioperatively . Also want investigate decrease mean number RBC unit receive per patient perioperative period .</detailed_description>
	<mesh_term>Anemia , Iron-Deficiency</mesh_term>
	<mesh_term>Iron</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>1 . Undergoing isolated Coronary Artery Bypass Grafting operation Aortic Valve Repair ( AVR ) . 2 . Preoperative Hb &lt; 7 mmol/l . 1 . Off pump surgery . 2 . Combination surgery . 3 . Reoperation . 4 . Emergency operation . 5 . Patients bleed disturbance ; e.g , hemophilia patient chronic liver disease . 6 . Concomitant use cyclosporine prior , follow surgery . 7 . Female patient pregnant plan become pregnant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Blood transfusion</keyword>
	<keyword>Erythropoietin</keyword>
	<keyword>Iron suppletion</keyword>
</DOC>